Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beat-HF: Mirabegron in chronic heart failure
NCT01876433Phase 2Completed
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of mirabegron in heart failure with reduced ejection fraction (HFrEF). Started Sep 2013; status: completed.
02
Drugs
mirabegron
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT01876433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876433.